Inventor
SHAW DAVID MATTHEW
GB10 patents
Patents
10 patentsUS9718827B2Aug 1, 2017
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA22 citations93
US8846917B2Sep 30, 2014
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA20 citations83
US12247021B2Mar 11, 2025
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA1 citations72
US11834441B2Dec 5, 2023
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA4 citations72
US11919887B2Mar 5, 2024
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA2 citations71
US11827627B2Nov 28, 2023
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA3 citations71
US10815239B2Oct 27, 2020
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US10160760B2Dec 25, 2018
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA3 citations71
US12258333B2Mar 25, 2025
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA0 citations60
US11485739B2Nov 1, 2022
Compounds useful as inhibitors of ATR kinase
VERTEX PHARMA0 citations60